Vulvar Disease pp 319-322 | Cite as

Paget’s Disease of the Vulva

  • Mila Pontremoli Salcedo
  • Kathleen M. SchmelerEmail author


Paget’s disease of the vulva is a rare vulvar neoplasm most commonly seen in postmenopausal women. The mean age at diagnosis has been reported to range from 50 to 80 years. Women commonly present with a well-demarcated pink eczematous lesion with white islands of hyperkeratosis, often accompanied by pruritus, vulvar pain, and erythema. Some women remain asymptomatic. Page’s disease may present as type 1, a primary cutaneous form, with two subtypes: 1a, intraepithelial Paget’s disease; 1b, intraepithelial disease with invasion; and 1c, intraepithelial Paget’s disease with underlying adenocarcinoma of a skin appendage or subcutaneous gland. Type 2 is metastasis from underlying malignancy of the gastrointestinal tract, and 2b is metastasis from the urogenital tract or adenocarcinoma originating elsewhere. Regardless of treatment, 12–62% of patients develop recurrent disease.

Surgical excision is recommended. Many studies have been demonstrated a high rate of positive margins despite radical surgery. Imiquimod is also efficacious, especially in women with recurrent disease after surgery or in those unable to undergo a surgery.


  1. 1.
    Paget J. On disease of the mammary areola preceding cancer of the mammary gland. Bartholomew’s Hosp Rep. 1874;10:87–9.Google Scholar
  2. 2.
    Shepherd V, Davidson EJ, Davies-Humphreys J. Extramammary Paget’s disease. BJOG. 2005;112(3):273–9.CrossRefGoogle Scholar
  3. 3.
    Crocker HR. Paget’s disease, affecting the scrotum and penis. Trans Pathol Soc Lond. 1889;40:187–91.Google Scholar
  4. 4.
    Dubreuilh W. Paget’s disease of the vulva. Br J Dermatol. 1901;13:403–13.CrossRefGoogle Scholar
  5. 5.
    Delport ES. Extramammary Paget’s disease of the vulva: an annotated review of the current literature. Australas J Dermatol. 2013 Feb;54(1):9–21. Scholar
  6. 6.
    Kay JM, Southwood WF. Paget’s disease of the vulva associated with an unusual bladder tumour. Br J Cancer. 1964;18:233–7.CrossRefGoogle Scholar
  7. 7.
    Preti M, Micheletti L, Ghiringhello B, Privitera S, Condello V, Chieppa P, et al. Vulvar Paget’s disease. Clinico-pathologic review of the literature. Minerva Ginecol. 2000;52(5):203–11.PubMedGoogle Scholar
  8. 8.
    Tebes S, Cardosi R, Hoffman M. Paget’s disease of the vulva. Am J Obstet Gynecol. 2002;187(2):281–3.CrossRefGoogle Scholar
  9. 9.
    Black D, Tornos C, Soslow RA, Awtrey CS, Barakat RR, Chi DS, et al. The outcomes of patients with positive margins after excision for intraepithelial Paget’s disease of the vulva. Gynecol Oncol. 2007;104(3):547–50.CrossRefGoogle Scholar
  10. 10.
    Parashurama R, Nama V, Hutson R. Paget’s disease of the vulva: a review of 20 years’ experience. Int J Gynecol Cancer. 2017;27:791–3.CrossRefGoogle Scholar
  11. 11.
    Borghi C, Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, et al. Invasive Paget disease of the vulva. Int J Gynecol Cancer. 2018;28(1):176–82.CrossRefGoogle Scholar
  12. 12.
    Nitecki R, Davis M, Watkins JC, Wu YE, Vitonis AF, Muto MG, et al. Extramammary Paget disease of the vulva: a case series examining treatment, recurrence, and malignant transformation. Int J Gynecol Cancer. 2018;28(3):632–8. Scholar
  13. 13.
    Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol. 2002;33(5):549–54.CrossRefGoogle Scholar
  14. 14.
    Feuer GA, Shevchuk M, Calanog A. Vulvar Paget’s disease: the need to exclude an invasive lesion. Gynecol Oncol. 1990;38(1):81.CrossRefGoogle Scholar
  15. 15.
    Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A. Interventions for the treatment of Paget’s disease of the vulva. Cochrane Database Syst Rev. 2013;10:CD009245.Google Scholar
  16. 16.
    Fanning J, Lambert L, Hale TM, Morris PC, Schuerch C. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180(1 Pt 1):24–7.CrossRefGoogle Scholar
  17. 17.
    Parker LP, Parker JR, Bodurka-Bevers D, Deavers M, Bevers MW, Shen-Gunther J, Gershenson DM. Paget’s disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol. 2000;77:183–9.CrossRefGoogle Scholar
  18. 18.
    Onaiwu CO, Salcedo MP, Pessini SA, Munsell MF, Euscher EE, Reed KE, Schmeler KM. Paget’s disease of the vulva: a review of 89 cases. Gynecol Oncol Rep. 2016;19:46–9.CrossRefGoogle Scholar
  19. 19.
    Machida H, Moeini A, Roman LD, Matsuo K. Effects of imiquimod on vulvar Paget’s disease: a systematic review of literature. Gynecol Oncol. 2015;139:165–71.CrossRefGoogle Scholar
  20. 20.
    Dogan A, Hilal Z, Krentel H, Cetin C, Hefler LA, Grimm C, et al. Paget’s disease of the vulva treated with imiquimod: case report and systematic review of the literature. Gynecol Obstet Investig. 2017;82(1):1–7.CrossRefGoogle Scholar
  21. 21.
    Hatch KD, Davis JR. Complete resolution of Paget disease of the vulva with imiquimod cream. J Low Genit Tract Dis. 2008;12(2):90–4.CrossRefGoogle Scholar
  22. 22.
    Luyten A, Sörgel P, Gieseking F, Maass-Poppenhusen K, Lellé RJ, Harter P, et al. Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network. J Am Acad Dermatol. 2014;70(4):644–50.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Mila Pontremoli Salcedo
    • 1
  • Kathleen M. Schmeler
    • 2
    Email author
  1. 1.Federal University of Health Sciences Porto Alegre (UFCSPA)/Irmandade Santa Casa de Misericordia de Porto AlegrePorto AlegreBrazil
  2. 2.Department of Gynecologic Oncology and Reproductive MedicineThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations